Influenza Laboratory Network
under IDSP
INFLUENZA LAB NETWORK UNDER IDSP
• Network of 12 laboratories
– 10 labs functional
– 2 new labs being strengthened
• One national reference laboratory at NCDC
INFLUENZA LAB NETWORK UNDER
IDSP
JIPMER
Pondicherry
IGMC Shimla
SGPGI
Lucknow
Haffkines
Mumbai
NCDC, Delhi
CRI Kasauli
NIMHANS
Bangalore
IPM
Hyderabad
BJ Medical College
Ahmedabad
Manipal
Medical College
NEiGRIHMS
PGI
PGI partially functional, being strengthened. NEIGRIHMS being established
Financial component
For 10 existing labs
2 new labs
Total (in
INR)
Non- Recurring grant
towards procurement
of lab equipments
from CSU
For each lab Rs. 2.6 lacs
For 10 labs - Rs. 26 lacs
For each lab Rs. 40.6 lacs
For 2 labs - Rs 81.2 lacs
107.2 lacs
Recurring grant
towards purchase of
kits and reagents
from CSU
(proprietary items
and difficult to
procure)
For each lab Rs. 12.16 lacs
For 10 labs - Rs. 121.6 lacs
For each lab Rs. 12.16 lacs
For 2 labs - Rs. 24.32 lacs
145.92lacs
Recurring grant
towards operating
expenditure and staff
salary to be released
to the labs
For each lab Rs. 11.2 lacs
For 2 labs - Rs. 112 lacs
For each lab Rs. 11.2 lacs
For 2 labs - Rs. 22.4 lacs
134.4 lacs
Total
387.52 lacs
Current status
• MoU with 12 laboratories signed
• Annual contingency funds (Rs 11.2 lakhs) released to 12
labs including salary of 1 lab technician)
• Procurement of equipment and reagents under process
• ILI and SARI surveillance plan approved,
communications sent to SSOs of 11 states involved in
this surveillance plan (Andhra Pradesh, UP, Puducherry,
Meghalaya, Karnataka, Maharashtra, Kerala, Gujarat,
HP, Chandigarh, Punjab)
• Training for all 12 labs held at National reference lab at
NCDC from 25-29 April 2011
Laboratory based Influenza (SARI/ILI)
Surveillance Plan India:
Under IDSP AI Lab Network
Goal: To set up a sustainable surveillance
system for influenza in India
Specific Objectives:
– To provide data for better informed action regarding national
and local influenza prevention and control efforts, including
vaccination campaigns. These include data on:
• epidemiology and seasonality data of influenza;
• groups at high risk for severe outcomes, including
hospitalization and deaths;
– To provide influenza virus isolates for monitoring changes in
viral antigens, antiviral susceptibility and for the development
of new vaccines;
– To provide a platform for surveillance that includes additional
common respiratory pathogens (e.g. Respiratory syncytial
virus (RSV), Adenovirus, Para influenza viruses, and
Rhinovirus);
Selection of Sentinel Sites
• All the AI labs under the network will identify three
sentinel sites on the basis of the following criteria :
-- Feasibility
--Patient representativeness
• The facility (ies) should provide care for patients of all
ages presenting with a wide range of medical conditions
including infectious diseases and chronic medical
conditions.
Selection of cases for surveillance
• Pediatric and /or medical depts of the sentinel
site will be included for sample (Throat swab
/nasal swab) collection.
• Routine ILI or ARI surveillance: outpatient
department
• SARI surveillance: hospitalized respiratory
illness
SARI
surveillance
Sentinel site nodal person
medical / pediatric ward
Microbiology division of the sentinel site
will store it in optimum required
temperature.
Collect samples (Throat swab /nasal swab) of all
admitted SARI patients of one week and store
in microbiology division of the hospital on daily
basis.
Influenza lab technician will collect the SARI
samples stored in the sentinel site for the
previous week on a weekly basis
Influenza laboratory will conduct
further testing
Report and feedback from
influenza laboratory to NCDC,
SSO, and the sentinel site on
weekly basis
ARI/ILI
surveillance
Influenza lab technician will collect samples (throat
swab & nasal swab) from the OPD
Visit to each sentinel site medical or
pediatric OPD once in a week
Collect First 5 samples (throat swab & nasal
swab) of ILI cases from the OPD. Collect P
form data of ARI /ILI of previous week
ILI Samples along with SARI samples of
the previous week sent to / brought to
Influenza lab
Influenza laboratory will conduct further
testing
Report and feedback from
influenza laboratory to NCDC,
SSO, and the sentinel site on
weekly basis
Thank you
Procurement status
Equipment:
• Shopping: Total 12 equipment (14 packages)
– 5 equipment (UV spectrophotometer, Lab refrigerator, high speed
microcentrifuge, CO2 incubator, - 85 degree deep freezer) (7 packages) -
Purchase committee approval done, purchase order
being issued
– 2 equipment (Fully auto. TC glassware system & water purification
system) – 3 technically compatible quotations received,
only 2 commercially compatible, comments form WB
awaited
– 3 equipment (3 packages)- Being put up to Purchase
committee for approval
– 2 equipment (2 packages): < 3 technically compatible
quotations received, comments from WB awaited
• NCB: (Total 4 equipment) Will be advertised by July last
week
Procurement status-2
Reagents:
•
Direct Contracting: (Total 6)
–
–
•
2 reagents – high value, being procured by
Procurement cell, MoHFW
4 reagents (Direct contracting)- All approvals done,
Purchase order issued and reagents delivered
Shopping: (Total 9)
–
–
–
1 reagent- Purchase committee approval obtained,
Purchase order being issued
5 reagents- Despite retender < 3 quotations
received, comments form WB awaited
3 reagents - Bid evaluation done, being put up to
purchase committee for approval
Procurement status-3
• Printing of manuals
– All approvals done, Purchase order being issued
• SHOC
– high value purchase, being procured by Procurement
cell, Dte GHS, Bidding document sent to World Bank
for no objection